<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moreira TG</submitter><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>17655</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4668385</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5</volume><pubmed_abstract>The Sec13 protein functions in various intracellular compartments including the nuclear pore complex, COPII-coated vesicles, and inside the nucleus as a transcription regulator. Here we developed a mouse model that expresses low levels of Sec13 (Sec13(H/-)) to assess its functions in vivo, as Sec13 knockout is lethal. These Sec13 mutant mice did not present gross defects in anatomy and physiology. However, the reduced levels of Sec13 in vivo yielded specific immunological defects. In particular, these Sec13 mutant mice showed low levels of MHC I and II expressed by macrophages, low levels of INF-γ and IL-6 expressed by stimulated T cells, and low frequencies of splenic IFN-γ+CD8+ T cells. In contrast, the levels of soluble and membrane-bound TGF-β as well as serum immunoglobulin production</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo.</pubmed_title><pmcid>PMC4668385</pmcid><funding_grant_id>R01 AI079110</funding_grant_id><funding_grant_id>R01 GM096070</funding_grant_id><funding_grant_id>R01 GM113874-01</funding_grant_id><funding_grant_id>R01 GM113874</funding_grant_id><funding_grant_id>GM096070</funding_grant_id><funding_grant_id>P30 CA142543</funding_grant_id><funding_grant_id>R01 AI089539</funding_grant_id><pubmed_authors>Shelton J</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Shaulov L</pubmed_authors><pubmed_authors>Williams J</pubmed_authors><pubmed_authors>Sakthivel R</pubmed_authors><pubmed_authors>Nussenzveig DR</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Kuss SK</pubmed_authors><pubmed_authors>Moreira TG</pubmed_authors><pubmed_authors>Somatilaka B</pubmed_authors><pubmed_authors>Faria AM</pubmed_authors><pubmed_authors>Seemann J</pubmed_authors><pubmed_authors>Fontoura BM</pubmed_authors><pubmed_authors>Harel A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo.</name><description>The Sec13 protein functions in various intracellular compartments including the nuclear pore complex, COPII-coated vesicles, and inside the nucleus as a transcription regulator. Here we developed a mouse model that expresses low levels of Sec13 (Sec13(H/-)) to assess its functions in vivo, as Sec13 knockout is lethal. These Sec13 mutant mice did not present gross defects in anatomy and physiology. However, the reduced levels of Sec13 in vivo yielded specific immunological defects. In particular, these Sec13 mutant mice showed low levels of MHC I and II expressed by macrophages, low levels of INF-γ and IL-6 expressed by stimulated T cells, and low frequencies of splenic IFN-γ+CD8+ T cells. In contrast, the levels of soluble and membrane-bound TGF-β as well as serum immunoglobulin production</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Dec</publication><modification>2025-04-04T14:06:26.448Z</modification><creation>2019-03-27T02:04:32Z</creation></dates><accession>S-EPMC4668385</accession><cross_references><pubmed>26631972</pubmed><doi>10.1038/srep17655</doi></cross_references></HashMap>